INS and metabolic dysfunction-associated steatotic liver disease: Fasting insulin: Fasting insulin levels were significantly higher in NAFLD patients compared to healthy individuals, with a pooled mean difference of 4.45 (95% CI: 3.29-5.62, p < 0.0001).